Protective effects of antidepressant citalopram against abnormal APP processing and amyloid beta-induced mitochondrial dynamics, biogenesis, mitophagy and synaptic toxicities in Alzheimer’s disease DOI Open Access
Arubala P. Reddy,

Xiangling Yin,

Neha Sawant

и другие.

Human Molecular Genetics, Год журнала: 2021, Номер 30(10), С. 847 - 864

Опубликована: Фев. 16, 2021

The purpose of this study is to the neuroprotective role selective serotonin reuptake inhibitor (SSRI), citalopram, against Alzheimer's disease (AD). Multiple SSRIs, including are reported treat patients with depression, anxiety and AD. However, their protective cellular mechanisms have not been studied completely. In current study, we investigated citalopram impaired mitochondrial dynamics, defective biogenesis, mitophagy synaptic dysfunction in immortalized mouse primary hippocampal cells (HT22) expressing mutant APP (SWI/IND) mutations. Using quantitative RT-PCR, immunoblotting, biochemical methods transmission electron microscopy methods, assessed full-length APP/C-terminal fragments Aβ levels mRNA protein genes mAPP-HT22 treated citalopram. Increased fission genes, decreased fusion autophagy, were found relative WT-HT22 cells. compared revealed reduced increased fusion, genes. Our data agree levels. Transmission significantly numbers length cells; these reversed citalopram-treated Cell survival rates citalopram-untreated mAPP-HT22. Further, mAPP C-terminal werealso These findings suggest that reduces toxicities may a Aβ-induced injuries

Язык: Английский

Neuroinflammation in Alzheimer’s Disease DOI Creative Commons
Isaac G. Onyango, Gretsen Velezmoro Jáuregui, Mária Čarná

и другие.

Biomedicines, Год журнала: 2021, Номер 9(5), С. 524 - 524

Опубликована: Май 7, 2021

Alzheimer's disease (AD) is a neurodegenerative associated with human aging. Ten percent of individuals over 65 years have AD and its prevalence continues to rise increasing age. There are currently no effective modifying treatments for AD, resulting in increasingly large socioeconomic personal costs. Increasing age an increase low-grade chronic inflammation (inflammaging) that may contribute the process AD. Although exact mechanisms remain unclear, aberrant elevation reactive oxygen nitrogen species (RONS) levels from several endogenous exogenous processes brain not only affect cell signaling, but also trigger cellular senescence, inflammation, pyroptosis. Moreover, compromised immune privilege allows infiltration peripheral cells infectious agents play role. Additionally, meta-inflammation as well gut microbiota dysbiosis drive neuroinflammatory process. Considering inflammatory/immune pathways dysregulated parallel cognitive dysfunction elucidating relationship between central nervous system facilitate development safe therapy We discuss some current ideas on inflammaging appear summarize details few immunomodulatory strategies being developed selectively target detrimental aspects neuroinflammation without affecting defense against pathogens tissue damage.

Язык: Английский

Процитировано

204

Cellular senescence at the crossroads of inflammation and Alzheimer's disease DOI
Ana Guerrero, Bart De Strooper, I. Lorena Arancibia-Cárcamo

и другие.

Trends in Neurosciences, Год журнала: 2021, Номер 44(9), С. 714 - 727

Опубликована: Авг. 5, 2021

Язык: Английский

Процитировано

165

Defective mitophagy and synaptic degeneration in Alzheimer's disease: Focus on aging, mitochondria and synapse DOI

Hallie Morton,

Sudhir Kshirsagar,

Erika Orlov

и другие.

Free Radical Biology and Medicine, Год журнала: 2021, Номер 172, С. 652 - 667

Опубликована: Июль 8, 2021

Язык: Английский

Процитировано

127

Epigallocatechin-3-Gallate (EGCG): New Therapeutic Perspectives for Neuroprotection, Aging, and Neuroinflammation for the Modern Age DOI Creative Commons
Ashley Payne, Samuel N. Nahashon,

Equar Taka

и другие.

Biomolecules, Год журнала: 2022, Номер 12(3), С. 371 - 371

Опубликована: Фев. 25, 2022

Alzheimer’s and Parkinson’s diseases are the two most common forms of neurodegenerative diseases. The exact etiology these disorders is not well known; however, environmental, molecular, genetic influences play a major role in pathogenesis Using disease (AD) as archetype, pathological findings include aggregation Amyloid Beta (Aβ) peptides, mitochondrial dysfunction, synaptic degradation caused by inflammation, elevated reactive oxygen species (ROS), cerebrovascular dysregulation. This review highlights neuroinflammatory neuroprotective epigallocatechin-3-gallate (EGCG): medicinal component green tea, known nutraceutical that has shown promise modulating AD progression due to its antioxidant, anti-inflammatory, anti-aging abilities. report also re-examines current literature provides innovative approaches for EGCG be used preventive measure alleviate other disorders.

Язык: Английский

Процитировано

108

Role of Nrf2 in aging, Alzheimer’s and other neurodegenerative diseases DOI Creative Commons
Mathew George, Matthan Tharakan,

John Culberson

и другие.

Ageing Research Reviews, Год журнала: 2022, Номер 82, С. 101756 - 101756

Опубликована: Окт. 13, 2022

Язык: Английский

Процитировано

104

Mitochondrial DNA Release in Innate Immune Signaling DOI Creative Commons
Laura Newman, Gerald S. Shadel

Annual Review of Biochemistry, Год журнала: 2023, Номер 92(1), С. 299 - 332

Опубликована: Март 31, 2023

According to the endosymbiotic theory, most of DNA original bacterial endosymbiont has been lost or transferred nucleus, leaving a much smaller (∼16 kb in mammals), circular molecule that is present-day mitochondrial (mtDNA). The ability mtDNA escape mitochondria and integrate into nuclear genome was discovered budding yeast, along with genes regulate this process. Mitochondria have emerged as key regulators innate immunity, it now recognized released cytoplasm, outside cell, circulation activates multiple immune signaling pathways. Here, we first review mechanisms through which including several inducible pores defective mitophagy autophagy. Next, cover how different forms activate specific nucleic acid sensors inflammasomes. Finally, discuss intracellular extracellular release, circulating cell-free promotes systemic inflammation, are implicated human diseases, viral infections, senescence aging.

Язык: Английский

Процитировано

97

Telomeres and Mitochondrial Metabolism: Implications for Cellular Senescence and Age-related Diseases DOI Open Access

Xingyu Gao,

Xiao Yu,

Chang Zhang

и другие.

Stem Cell Reviews and Reports, Год журнала: 2022, Номер 18(7), С. 2315 - 2327

Опубликована: Апрель 23, 2022

Язык: Английский

Процитировано

93

Mitochondrial dysfunctions, oxidative stress and neuroinflammation as therapeutic targets for neurodegenerative diseases: An update on current advances and impediments DOI
Muneeb U. Rehman, Nouroz Sehar, Nawab John Dar

и другие.

Neuroscience & Biobehavioral Reviews, Год журнала: 2022, Номер 144, С. 104961 - 104961

Опубликована: Ноя. 14, 2022

Язык: Английский

Процитировано

75

Autophagy in aging-related diseases and cancer: Principles, regulatory mechanisms and therapeutic potential DOI
Na Wu, Wenhui Zheng,

Yundong Zhou

и другие.

Ageing Research Reviews, Год журнала: 2024, Номер 100, С. 102428 - 102428

Опубликована: Июль 20, 2024

Язык: Английский

Процитировано

19

mTOR in Alzheimer disease and its earlier stages: Links to oxidative damage in the progression of this dementing disorder DOI
Marzia Perluigi, Fabio Di Domenico, Eugenio Barone

и другие.

Free Radical Biology and Medicine, Год журнала: 2021, Номер 169, С. 382 - 396

Опубликована: Апрель 30, 2021

Язык: Английский

Процитировано

92